Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-01
2007-05-01
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S397000, C514S336000, C546S173000, C546S268400, C546S272100, C548S346100
Reexamination Certificate
active
09997323
ABSTRACT:
Substituted imidazoles and thiazoles having the formulaare useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient.
REFERENCES:
patent: 5030644 (1991-07-01), Baldwin et al.
patent: 5245061 (1993-09-01), Singh
patent: 5624947 (1997-04-01), Keown et al.
patent: 5714479 (1998-02-01), Ishikawa et al.
patent: 5854264 (1998-12-01), Anthony et al.
patent: 5854265 (1998-12-01), Anthony
patent: 5859035 (1999-01-01), Anthony et al.
patent: 5872136 (1999-02-01), Anthony et al.
patent: 5874452 (1999-02-01), Anthony
patent: 5880140 (1999-03-01), Anthony
patent: 5883105 (1999-03-01), Anthony
patent: 5939557 (1999-08-01), Anthony et al.
patent: 6080870 (2000-06-01), Anthony
patent: 6143766 (2000-11-01), Kaltenbronn et al.
patent: 97/36875 (1997-10-01), None
patent: 97/36876 (1997-10-01), None
patent: 97/36881 (1997-10-01), None
patent: 97/36897 (1997-10-01), None
patent: 97/36901 (1997-10-01), None
patent: 99/17777 (1999-04-01), None
patent: 99/18096 (1999-04-01), None
patent: 99/20609 (1999-04-01), None
patent: 99/27928 (1999-06-01), None
patent: 99/27929 (1999-06-01), None
patent: 99/27933 (1999-06-01), None
patent: 99/28313 (1999-06-01), None
patent: 99/28314 (1999-06-01), None
patent: 00/12498 (2000-03-01), None
Caplus Abstract DN 114:42649 Brian Phillips et al 1990.
Goldstein, J.L. et al., “Nonfarnesylated Tetrapeptide Inhibitors of Protein Farnesyltransferase,” Journal of Biological Chemistry 266(24):15575-15578 (1991).
IUPAC, IUPAC “Commission on Nomenclature of Organic Chemistry, Rules for the Nomenclature of Organic Chemistry,” 45:13-30 (1976).
Moores, S.L. et al., “Sequence Dependence of Protein Isoprenylation,” Journal of Biological Chemistry 266(22):14603-14610 (1991).
Reiss, Y. et al., “Inhibition of Purified p21rasFarnesyl:Protein Transferase by Cys-AAX Tetrapeptides,” Cell 62:81-88 (1990).
Vogt, A. et al., “Non-Peptide Mimetic of Ras-CAAX: Selective Inhibition of Farnesyltransferase and Ras Processing,” Journal of Biological Chemistry 270(2):660-664 (1995).
Claiborne Akiyo K.
Gwaltney, II Stephen L.
Hasvold Lisa A.
Li Qun
Li Tongmei
Abbott Laboratories
Corbin Johanna M.
Desai Rita
Steele Gregory W.
LandOfFree
Farnesyltransferase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Farnesyltransferase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Farnesyltransferase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3727507